SELLAS LIFE SCIENCES GROUP INC stock forecast: up to 2.17 USD SLS stock price prognosis

STOCK

Forecast for Tue 29 Nov 2022 price 2.68

SELLAS LIFE SCIENCES GROUP INC stock price forecast for further price development up to 7.62% (time horizon: 1 day) and price target of 2.17 USD. Negative news sentiment. Short-term (time horizon: 2 weeks) SELLAS LIFE SCIENCES GROUP INC share price prediction for 2022-11-29 with daily closed price projections

Key Facts

Symbol SLS 

ISIN US81642T2096 

CUSIP 81642T209


Currency USD


Category Pharmaceutical Preparations

Forecast price change %


News sentiment (-0.22)


News <--> Close correlation for next day influence (-0.20)

Finance numbers

Revenue 7,600,000.0


Earnings per share -1.61


On our site we made daily predictions for finance products based on statistical analysis. You can export / download forecasted data as CSV file, no login required. The information can be used for day trading.

The forecast (dashed curve) of the share price performance is based on historical data. Our forecast model is based on mathematical, statistical methods. The website offers price forecasts and analysis tools for equities and other securities, which are exclusively based on the prices of these securities in the past. Information about these prices is provided to us by third parties. Although we believe, If we believe that our sources are reliable, we cannot guarantee the accuracy, completeness, timeliness and correct sequencing of this information. We do not investigate the issuers of the securities to which our forecasts relate, nor do we consider any financial data or other data of such issuers with the exception of the past prices of the securities. Therefore, our forecasts do not constitute an analysis of other commercial or financial factors or circumstances, that may be relevant for future security price flows. Investments require additional considerations. Our forecasts cannot reflect the specific situation. Experience and risk profile of an individual investor or the tax implications an investment may have for the investor. Although we believe that our mathematical models are a tool to try to explore the possibility for future price development with the help of past performance, such developments are subject to a multitude of different influences. and therefore not really predictable. We cannot guarantee the success of any investment you make based on the information published here. This website is for information purposes only. All information and data on this website cannot be guaranteed to be accurate, accuracy, completeness and appropriateness - neither explicit nor implicit.

Summerized Form 10-K with GPT-2

We have retained sole rights to GPS and GPS+ outside of the Greater China area. The B-cells "helped" by the helper T cells produce antibodies to specific WT1 epitopes. AML most commonly affects adults, and its incidence increases with age. This was a statistically significant difference (p=0.0175). Certain newly initiated sites have taken longer than expected to be fully operational. Data from this Phase 2 clinical trial was presented in 2016. In this study, treatment was continued until disease progression or toxicity. This clinical study was initiated in December 2018. The tumor type currently being investigated is ovarian cancer (second or third line). Six of the eight evaluable patients are continuing to receive GPS plus pembrolizumab. The FDA will not approve a BLA without a REMS, if one is required. A decision from the Supreme Court is expected to be issued in spring 2021. The BPCIA is complex and only beginning to be interpreted and implemented by the FDA. Violations of the FCA can result in significant monetary penalties and treble damages. Unlike Medicare Part A and B, Part D coverage is not standardized. On September 26, 2011, we changed our name to Galena Biopharma, Inc., or Galena. We do not expect to generate revenues for many years, if at all. We currently have no source of revenues from product sales. A failure of one or more clinical trials can occur at any stage of testing. Consequently, we may be subject to risks related to operating in foreign countries. We have determined that we will not engage in further development of NPS. The full impact of these decisions is not yet known. Litigation may be necessary to defend against these types of claims. The market price of shares of our common stock has exhibited substantial volatility.

Summerized Form 10-K with GPT-2 https://www.sec.gov/Archives/edgar/data/1390478/000139047821000007/0001390478-21-000007.txt
Candlestick patterns

Candlestick patterns can be used as additional information for price prediction. Following list show which pattern applies on latest price information.

  • Meta analyst score 40.00/100

Institutional ownership list is based on filling form information

Holding name Date Amount
Engineers Gate Manager LP 2021-03-31 26151
XR Securities LLC 2021-06-30 13100
Cutler Group LP 2021-06-30 6900
Cutler Group LP 2021-06-30 3500
CITADEL ADVISORS LLC 2021-03-31 86699

Fund ownership list is based on filling form information

Fund name Date Amount Profile
Fidelity Concord Street Trust 2021-05-31 12983 Long
SCHWAB CAPITAL TRUST 2021-04-30 4570 Long
DFA INVESTMENT DIMENSIONS GROUP INC 2021-04-30 9207 Long
DFA INVESTMENT DIMENSIONS GROUP INC 2021-04-30 3500 Long
RBB Fund, Inc. 2021-05-31 11400 Long

Bollinger Bollinger Bands for SELLAS LIFE SCIENCES GROUP INC can provide the information where the market is moving based on price information.


SELLAS LIFE SCIENCES GROUP INC Short Volume Ratio is shown in the diagram. Short volume sales can be seen as an investor sentiment.


On-Balance Volume information for SELLAS LIFE SCIENCES GROUP INC. On-Balance Volume information can be an indicator for bullish or bearish outcome.


Accumulation / Distribution (A/D) indicator information for SELLAS LIFE SCIENCES GROUP INC. The indicator identify divergences between price and volume flow.


Aroon Oscillator information for SELLAS LIFE SCIENCES GROUP INC. The trend-following indicator can show the strengh of a current trend and likelihood that trend can continue.


Average Directional Index (ADX) information for SELLAS LIFE SCIENCES GROUP INC. The index can be used to identify the strengh of a trend.


Moving Average Convergence Divergence (MACD) for SELLAS LIFE SCIENCES GROUP INC. The indicator helps to predict trend direction and the momentum of the trend.


Stochastic Oscillator as momentum indicator for SELLAS LIFE SCIENCES GROUP INC. The indicator is useful for identifying overbought and oversold levels.


Relative Strength Index (RSI) for SELLAS LIFE SCIENCES GROUP INC. RSI is a momentum oscillator that measures the speed and change of price development. The momentum indicator was created by analyst Welles Wilder. The result compares recent gains and losses over restricted time period. Primary usage of the indicator is to identify overbought or oversold signals. When RSI indicator reaches a value of 70 it could mean that speculators should consider selling, suggests Wilder and Chong. Or vice versa when selling excess at which the RSI Indicators show a value of 30 [ Relative Strength Index for Developing Effective Trading Strategies in Constructing Optimal Portfolio ].


52W High 52W Low Market Cap

Similar shares


SELLAS LIFE SCIENCES GROUP INC on Nasdaq

SELLAS LIFE SCIENCES GROUP INC on finviz

Figure below show the stock predictions.
Date Closing price Prediction was updated
2022-10-06 2.17 2022-10-04 17:10
2022-10-07 2.21 2022-10-04 17:10
2022-10-10 2.23 2022-10-04 17:10
2022-10-11 2.27 2022-10-04 17:10
2022-10-21 2.35 2022-10-04 17:10
2022-10-04 2.25 2022-10-01 16:38
2022-10-05 2.12 2022-10-04 17:10
2022-10-12 2.29 2022-10-04 17:10
2022-10-13 2.29 2022-10-04 17:10
2022-10-14 2.29 2022-10-04 17:10
2022-10-17 2.29 2022-10-04 17:10
2022-10-18 2.31 2022-10-04 17:10
2022-10-19 2.33 2022-10-04 17:10
2022-10-20 2.33 2022-10-04 17:10
2022-10-24 2.37 2022-10-04 17:10
2022-10-25 2.37 2022-10-04 17:10
2022-10-26 2.38 2022-10-04 17:10
2022-10-27 2.39 2022-10-04 17:10
2022-10-28 2.40 2022-10-04 17:10
2022-10-31 2.42 2022-10-04 17:10
2022-11-01 2.44 2022-10-04 17:10
2022-11-02 2.45 2022-10-04 17:10
2022-11-03 2.47 2022-10-04 17:10
2022-11-04 2.48 2022-10-04 17:10
2022-11-07 2.49 2022-10-04 17:10
2022-11-08 2.50 2022-10-04 17:10
2022-11-09 2.52 2022-10-04 17:10
2022-11-10 2.53 2022-10-04 17:10
2022-11-11 2.54 2022-10-04 17:10
2022-11-14 2.55 2022-10-04 17:10
2022-11-15 2.57 2022-10-04 17:10
2022-11-16 2.58 2022-10-04 17:10
2022-11-17 2.59 2022-10-04 17:10
2022-11-18 2.60 2022-10-04 17:10
2022-11-21 2.61 2022-10-04 17:10
2022-11-22 2.62 2022-10-04 17:10
2022-11-23 2.64 2022-10-04 17:10
2022-11-24 2.65 2022-10-04 17:10
2022-11-25 2.66 2022-10-04 17:10
2022-11-28 2.67 2022-10-04 17:10
2022-11-29 2.68 2022-10-04 17:10